Sumio Kiyoto is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of pharmacology, particularly through his innovative work on novel peptides. With a total of 6 patents to his name, Kiyoto's inventions have the potential to impact the treatment of various medical conditions.

Latest Patents

Kiyoto's latest patents include a process for producing WS-9326A and WS-9326B. These novel peptides, along with their derivatives and pharmaceutically acceptable salts, exhibit useful pharmacological activities, especially in the treatment and prevention of asthma and pain. The method described for producing these peptides utilizes Streptomyces violaceoniger No. 9326 in a biologically pure form. Additionally, his invention relates to the peptides WS-9326A and WS-9326B, their derivatives, and their uses in addressing asthma and pain.

Career Highlights

Sumio Kiyoto is associated with Fujisawa Pharmaceutical Company, Ltd., where he has been able to apply his expertise in pharmacology. His work has contributed to advancements in the development of therapeutic agents that can improve patient outcomes.

Collaborations

Kiyoto has collaborated with notable coworkers, including Motoaki Nishikawa and Masakuni Okuhara. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Sumio Kiyoto's contributions to the field of pharmacology through his innovative patents demonstrate his commitment to advancing medical science. His work on novel peptides has the potential to significantly improve treatments for asthma and pain, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com